Synthetic biology (synbio) has been a recent darling of venture capital funding, raking in billions and generating multiple recent IPOs. Moreover, synbio startups have demonstrated modest success, and some of...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)